Please assess the completion status of the following clinical trial:

Trial Title: Immunogenicity and Safety of Fractional Doses of Yellow Fever Vaccines (YEFE)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 12.0

Eligibility Criteria:
Inclusion Criteria:~* Adults population: 18 to 60 years of age~* Children population: 9 to 59 months of age~* For HIV positive population: HIV positive on serological testing~* If HIV infection, CD4 T-cell counts ≥200 cells/mm³ for adults or CD4 percentage \>25% for children~* Providing informed consent to participate in the study~Exclusion Criteria:~* Contraindications to yellow fever vaccination:~* History of yellow fever vaccination~* Previous yellow fever infection~* Requiring yellow fever vaccination for travelling purposes~* Pregnancy (as determined by a urine test on the proposed day of vaccination) and lactating women~* Refusal to participate in the study~* Planning to move out of the study area before the end of the study follow-up

- Gender: ALL
- Minimum Age: 9 Months
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Stamaril, Sanofi Pasteur: Standard dose (Type: ACTIVE_COMPARATOR): Subcutaneous administration of 1 dose of a standard yellow fever vaccine
- Stamaril, Sanofi Pasteur: Fractional dose (Type: EXPERIMENTAL): Subcutaneous administration of 1/5th of a standard dose of yellow fever vaccine
- Yellow fever vaccine, Bio-Manguinhos: Standard dose (Type: ACTIVE_COMPARATOR): Subcutaneous administration of 1 dose of a standard yellow fever vaccine
- Yellow fever vaccine, Bio-Manguinhos: Fractional dose (Type: EXPERIMENTAL): Subcutaneous administration of 1/5th of a standard dose of yellow fever vaccine
- Yellow fever vaccine, Institut Pasteur: Standard dose (Type: ACTIVE_COMPARATOR): Subcutaneous administration of 1 dose of a standard yellow fever vaccine
- Yellow fever vaccine, Institut Pasteur: Fractional dose (Type: EXPERIMENTAL): Subcutaneous administration of 1/5th of a standard dose of yellow fever vaccine
- Yellow fever vaccine, Chumakov Institute: Standard dose (Type: ACTIVE_COMPARATOR): Subcutaneous administration of 1 dose of a standard yellow fever vaccine
- Yellow fever vaccine, Chumakov Institute: Fractional dose (Type: EXPERIMENTAL): Subcutaneous administration of 1/5th of a standard dose of yellow fever vaccine
- YF, Chumakov Institute: Standard dose in Children (Type: ACTIVE_COMPARATOR): Subcutaneous administration of 1 dose of the yellow fever vaccine
- YF, Chumakov Institute: Fractional dose in Children (Type: EXPERIMENTAL): Subcutaneous administration of 1/5th of a standard dose of yellow fever vaccine
- YF, Chumakov Institute: Standard dose in HIV+ adults (Type: ACTIVE_COMPARATOR): Subcutaneous administration of 1 dose of the yellow fever vaccine
- YF, Chumakov Institute: Fractional dose in HIV+ adults (Type: EXPERIMENTAL): Subcutaneous administration of 1/5th of a standard dose of yellow fever vaccine

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: complete